(Q38279723)

English

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

tuberous sclerosis

1 reference

based on heuristic

inferred from title

subependymal giant cell astrocytoma

1 reference

based on heuristic

inferred from title

tuberous sclerosis 1

1 reference

based on heuristic

inferred from title

Elena Dmitrievna Belousova

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sergiusz Jóźwiak

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Steven Sparagana

object named as

Steven Sparagana

3

1 reference

ORCID Public Data File 2021

author name string

David Neal Franz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

E Martina Bebin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Michael Frost

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Rachel Kuperman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Olaf Witt

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Michael H Kohrman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

J Robert Flamini

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Joyce Y Wu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Paolo Curatolo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Petrus J de Vries

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Noah Berkowitz

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Oezlem Anak

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Julie Niolat

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

10 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1513-1520

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456370%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathogenesis and imaging of the tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging characteristics and growth of subependymal giant cell astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex: neurological, renal and pulmonary manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian toxicity from sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone concentrations and sirolimus in male renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

National Institutes of Health consensus conference: tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus alters white matter diffusion in tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970489-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38279723&oldid=1751747551"